 |
somatic cell therapy product containing hematopoietic progenitor cells (HPC), Facilitating Cells (FC), and alpha beta T cells. |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of organ rejection in living donor kidney transplant recipients |
| USA Market Approval | USA |
| USA Designation Date | 2016-02-04 00:00:00 |
| Sponsor | Regenerex LLC;570 South Preston Street, Suite 404;Louisville, Kentucky, 40202 |
